{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:34Z","timestamp":1787181874496,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Grant-in-Aid for Scientific Research, the Japan Society for the Promotion of Science","award":["20K17962"],"award-info":[{"award-number":["20K17962"]}]},{"name":"the Aichi Cancer Research Foundation"},{"name":"Nasu Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Spinal intramedullary tumors comprise a heterogeneous group of entities with diverse histopathological features, making their diagnosis particularly challenging. With the introduction of DNA methylation profiling, the underlying biological diversity of these tumors has been increasingly clarified and systematized; however, owing to the rarity of these tumors, case accumulation remains limited, and significant challenges persist. In this study, we identified two cases of spinal ependymal tumors exhibiting a methylation profile of spinal (SP-) subependymoma (SEPN). Both cases occurred in elderly patients and demonstrated circumscribed growth consistent with low-grade ependymal tumors; however, these tumors did not exhibit the typical histopathological features required for a diagnosis of SEPN in the 2021 WHO classification of central nervous system (CNS) tumors, showing indistinct cluster formation, an astrocytic immunohistochemical profile suggested by Olig2 expression, and relatively elevated Ki-67 labeling indices of 4.5% and 3.1%. At the molecular level, both cases harbored\n                    <jats:italic>telomerase reverse transcriptase<\/jats:italic>\n                    promoter mutations and whole chromosome 7 gain. On two-dimensional t-distributed stochastic neighbor embedding analysis, both clustered within the SP-SEPN methylation class at its periphery, with low classifier calibration scores (0.70 and 0.69). According to the current WHO classification, these cases are designated as low-grade ependymal tumors (CNS WHO grade 2) with methylation profile of SP-SEPN because they do not meet the essential WHO histopathological criteria. Ependymal tumors exhibiting a methylation profile consistent with SEPN, but discordant histopathological features have been increasingly recognized, and the appropriate classification of such tumors remains a subject of ongoing debate. These cases provide important insights into the histopathological diversity of ependymal tumors and contribute to establishing a more comprehensive and systematic classification of ependymal tumors.\n                  <\/jats:p>","DOI":"10.1186\/s40478-026-02334-7","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:04:11Z","timestamp":1781337851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spinal low-grade ependymal tumors harboring telomerase reverse transcriptase promoter mutation and chromosome 7 gain with methylation profile of spinal subependymoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Yoshitaka","family":"Nagashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Takido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiharu","family":"Ohka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"2334_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"key":"2334_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.14245\/ns.2244168.084","volume":"19","author":"Y Nagashima","year":"2022","unstructured":"Nagashima Y, Nishimura Y, Eguchi K, Yamaguchi J, Haimoto S, Ohka F, Takayasu M (2022) Saito. Recent molecular and genetic findings in intramedullary spinal cord tumors. Neurospine 19:262\u2013271","journal-title":"Neurospine"},{"key":"2334_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, et al. (2018) DNA methylation-based classification of central nervous system tumours. Nature. 555:469\u201374.","journal-title":"Nature"},{"key":"2334_CR4","first-page":"vdae228","volume":"7","author":"K Aldape","year":"2025","unstructured":"Aldape K, Capper D, von Deimling A, et al (2025) Wesseling. cIMPACT-NOW update 9: recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. Neurooncol Adv 7:vdae228","journal-title":"Neurooncol Adv"},{"key":"2334_CR5","unstructured":"Pajtler KW, Witt H, Sill M, et al (2015) Molecular classification of ependymal tumors across All CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728\u2009\u2013\u200943"},{"key":"2334_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/jjco\/hyad056","volume":"53","author":"J Yamaguchi","year":"2023","unstructured":"Yamaguchi J, Ohka F, Motomura K, Saito R (2023) Latest classification of ependymoma in the molecular era and advances in its treatment: a review. Jpn J Clin Oncol 53:653\u2013663","journal-title":"Jpn J Clin Oncol"},{"key":"2334_CR7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/neuonc\/noy118","volume":"20","author":"H Witt","year":"2018","unstructured":"Witt H, Gramatzki D, Hentschel B, Pajtler KW, Felsberg J, Schackert G, L\u00f6ffler M, Capper D, Sahm F, Sill M, von Deimling A, Kool M, Herrlinger U, Westphal M, Pietsch T, Reifenberger G, Pfister SM, Tonn JC (2018) Weller. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro Oncol 20:1616\u20131624","journal-title":"Neuro Oncol"},{"key":"2334_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, Schmid S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A, Wefers AK, Huang K, Sievers P, Ebrahimi A, Sch\u00f6ler A, Teichmann D, Koch A, H\u00e4nggi D, Unterberg A, Platten M, Wick W, Witt O, Milde T, Korshunov A (2018) Pfister; A. von Deimling. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136:181\u2013210","journal-title":"Acta Neuropathol"},{"key":"2334_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-019-02090-0","volume":"139","author":"JE Neumann","year":"2020","unstructured":"Neumann JE, Spohn M, Obrecht D, Mynarek M, Thomas C, Hasselblatt M, Dorostkar MM, Wefers AK, Frank S, Monoranu CM, Koch A, Witt H, Kool M, Pajtler KW, Rutkowski S, Glatzel M (2020) U. Sch\u00fcller. Molecular characterization of histopathological ependymoma variants. Acta Neuropathol 139:305\u2013318","journal-title":"Acta Neuropathol"},{"key":"2334_CR10","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1093\/neuonc\/noac088","volume":"24","author":"M Bockmayr","year":"2022","unstructured":"Bockmayr M, Harnisch K, Pohl LC, Schweizer L, Mohme T, K\u00f6rner; M, Alawi M, Suwala AK, Dorostkar MM, Monoranu CM, Hasselblatt M, Wefers AK, Capper D, Hench J, Frank S, Richardson TE, Tran I, Liu E, Snuderl M, Engertsberger L, Benesch M, von Deimling A, Obrecht D, Mynarek M, Rutkowski S, Glatzel M, Neumann JE (2022) U. Sch\u00fcller. Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease. Neuro Oncol 24:1689\u20131699","journal-title":"Neuro Oncol"},{"key":"2334_CR11","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, Teschendorff AE (2017) ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics 33:3982\u20133984","journal-title":"Bioinformatics"},{"key":"2334_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363\u20131369","journal-title":"Bioinformatics"},{"key":"2334_CR13","doi-asserted-by":"crossref","unstructured":"Chen BH, Zhou W (2024) mLiftOver: harmonizing data across Infinium DNA methylation platforms. Bioinformatics 40:btae423.","DOI":"10.1093\/bioinformatics\/btae423"},{"key":"2334_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-024-02740-y","volume":"147","author":"U Sch\u00fcller","year":"2024","unstructured":"Sch\u00fcller U, Gocke A, Godbole S, Delbridge C, Thomas C, Neumann JE (2024) Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas. Acta Neuropathol 147:83","journal-title":"Acta Neuropathol"},{"key":"2334_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00401-023-02674-x","volume":"147","author":"LC Pohl","year":"2024","unstructured":"Pohl LC, Leitheiser M, Obrecht D, Schweizer L, Wefers AK, Eckhardt A, Raffeld M, Sturm D, Pajtler KW, Rutkowski S, Fukuoka K, Ichimura K, Bockmayr M (2024) U. Sch\u00fcller. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas. Acta Neuropathol 147:24","journal-title":"Acta Neuropathol"},{"key":"2334_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3171\/2021.12.JNS211643","volume":"137","author":"J Rincon-Torroella","year":"2022","unstructured":"Rincon-Torroella J, Rakovec M, Khalafallah AM, Liu A, Bettegowda A, Kut C, Rodriguez FJ, Weingart J, Luciano M, Olivi A, Jallo GI, Brem H, Mukherjee D, Lim M (2022) Bettegowda. Clinical features and surgical outcomes of intracranial and spinal cord subependymomas. J Neurosurg 137:931\u2013942","journal-title":"J Neurosurg"},{"key":"2334_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3171\/2021.2.JNS204052","volume":"136","author":"BTS Kweh","year":"2022","unstructured":"Kweh BTS, Rosenfeld JV, Hunn M, Tee JW (2022) Tumor characteristics and surgical outcomes of intracranial subependymomas: a systematic review and meta-analysis. J Neurosurg 136:736\u2013748","journal-title":"J Neurosurg"},{"key":"2334_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.14245\/ns.2346388.194","volume":"20","author":"T Yagi","year":"2023","unstructured":"Yagi T, Mizuno M, Kageyama H, Tatebayashi K, Endo T, Takeshima Y, Iwasaki M, Kurokawa R, Takai K, Nishikawa M (2023) Hida. Spinal cord subependymoma: a subanalysis of the neurospinal society of Japan\u2019s multicenter study of intramedullary spinal cord tumors. Neurospine 20:735\u2013746","journal-title":"Neurospine"},{"key":"2334_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4103\/0976-3147.102630","volume":"3","author":"SS Krishnan","year":"2012","unstructured":"Krishnan SS, Panigrahi M, Pendyala S, Rao SI, Varma DR (2012) Cervical subependymoma: a rare case report with possible histogenesis. J Neurosci Rural Pract 3:366\u2013369","journal-title":"J Neurosci Rural Pract"},{"key":"2334_CR20","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1523\/JNEUROSCI.20-06-02218.2000","volume":"20","author":"PJ Horner","year":"2000","unstructured":"Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20:2218\u20132228","journal-title":"J Neurosci"},{"key":"2334_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3171\/2014.9.JNS14155","volume":"122","author":"Z Bi","year":"2015","unstructured":"Bi Z, Ren X, Zhang J, Jia W (2015) Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. J Neurosurg 122:49\u201360","journal-title":"J Neurosurg"},{"key":"2334_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-007-9411-6","volume":"85","author":"EJ Rushing","year":"2007","unstructured":"Rushing EJ, Cooper PB, Quezado M, Begnami M, Crespo A, Smirniotopoulos JG, Ecklund J, Olsen C (2007) Santi. Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neurooncol 85:297\u2013305","journal-title":"J Neurooncol"},{"key":"2334_CR23","doi-asserted-by":"crossref","unstructured":"D\u2019Amico RS, Praver M, Zanazzi GJ, Englander ZK, Sims JS, Samanamud JL, Ogden AT, McCormick PC, Feldstein NA, McKhann GM 2nd;, Sisti MB, Canoll P (2017) J.N. Bruce. Subependymomas are low-grade heterogeneous glial neoplasms defined by subventricular zone lineage markers. World Neurosurg 107:451\u2013463","DOI":"10.1016\/j.wneu.2017.08.009"},{"key":"2334_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00401-021-02300-8","volume":"141","author":"C Thomas","year":"2021","unstructured":"Thomas C, Thierfelder F, Tr\u00e4ger; M, Soschinski P, M\u00fcther M, Edelmann D, F\u00f6rster; A, Geiler C, Kim HY, Filipski K, Harter PN, Schittenhelm J, Eckert F, Ntoulias G, May SA, Stummer W, Onken J, Vajkoczy P, Sch\u00fcller U, Heppner FL, Capper D, Koch A, Kaul D, Paulus W, Hasselblatt M, Schweizer L (2021) TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma. Acta Neuropathol 141:959\u2013970","journal-title":"Acta Neuropathol"},{"key":"2334_CR25","doi-asserted-by":"crossref","unstructured":"Wesseling P, Capper D, Reifenberger G, Sarkar C, Hawkins C, Perry A, Kleinschmidt-DeMasters B, Komori T, Paulus W, Santosh V, van den Bent M, Weller M, Pfister SM, Tabori U, Figarella-Branger D, Orr BA (2025) D.N. Louis. cIMPACT-NOW update 11: proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors. Brain Pathol 36:e70035","DOI":"10.1111\/bpa.70035"},{"key":"2334_CR26","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/gb-2012-13-10-r84","volume":"13","author":"D Sproul","year":"2012","unstructured":"Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR (2012) Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 13:R84","journal-title":"Genome Biol"},{"key":"2334_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13073-014-0066-6","volume":"6","author":"T Witte","year":"2014","unstructured":"Witte T, Plass C, Gerhauser C (2014) Pan-cancer patterns of DNA methylation. Genome Med 6:66","journal-title":"Genome Med"},{"key":"2334_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","volume":"20","author":"JW Shay","year":"2019","unstructured":"Shay JW, Wright WE (2019) Telomeres and telomerase: three decades of progress. Nat Rev Genet 20:299\u2013309","journal-title":"Nat Rev Genet"},{"key":"2334_CR29","first-page":"61","volume":"76","author":"F Br\u00fcgger","year":"2017","unstructured":"Br\u00fcgger F, Dettmer MS, Neuenschwander M, Perren A, Marinoni I, Hewer E (2017) TERT promoter mutations but not the alternative lengthening of telomeres phenotype are present in a subset of ependymomas and are associated with adult onset and progression to ependymosarcoma. J Neuropathol Exp Neurol 76:61\u201366","journal-title":"J Neuropathol Exp Neurol"},{"key":"2334_CR30","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1038\/ncomms3185","volume":"4","author":"J Vinagre","year":"2013","unstructured":"Vinagre J, Almeida A, P\u00f3pulo; H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Sim\u00f5es M, Lima J (2013) M\u00e1ximo; P. Soares. Frequency of TERT promoter mutations in human cancers. Nat Commun 4:2185","journal-title":"Nat Commun"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02334-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:44:09Z","timestamp":1787179449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2334"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02334-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Institutional Review Board at Nagoya University Hospital (approval number: 2021\u2009\u2212\u20090451) and complied with all provisions of the World Medical Association Declaration of Helsinki. Tumor samples were collected intra-operatively upon receiving informed consent from the patients. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patients.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"171"}}